Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key appointments to the "NewCo" leadership team, including Richard J. Heppenstall as Executive Vice President and Chief Financial Officer. Additionally, the company announced ZimVie as the name for the planned spin-off company for the Spine and Dental businesses. Zimmer Biomet announced in February 2021 its intent to form a new independent, publicly traded company to optimize resource allocation and drive toward market leadership. That transaction process remains on track, with an expected close in mid-2022.
Heppenstall brings more than 25 years of broad corporate and operational finance experience to ZimVie, most recently serving as Chief Financial Officer of Breg, Inc., a global manufacturer and solutions provider of orthopedic braces, cold therapy and other medical equipment.
"Rich is joining ZimVie at an instrumental time for the company, as we continue to shape our operating model and business plans in preparation for the planned spin-off," said Vafa Jamali, CEO of ZimVie. "His extensive experience across all areas of finance within the medtech space will be critically important as we advance toward the formation of a new independent company for our Spine and Dental businesses."
Heppenstall previously held senior leadership roles at Orthofix International, Solera Holdings, Flowserve Corporation and Coopervision Inc., among others. He holds a master's degree in Business Administration from
In addition to Heppenstall, the following team members have been appointed to the ZimVie leadership team, reporting directly to Jamali.
"I'm incredibly excited to bring on such a seasoned leadership team to drive ZimVie forward following the separation. With their collective experience, I know we have the right leaders in place to set ZimVie up for success," continued Mr. Jamali.
About the Company
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.